InnovationNew Jersey
  • Home
  • Our Coalition
    • Who We Are
    • Contact Us
  • News
  • Events
  • Join Us
  • Resources
    • Mapping NJ Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
    • Industry Supports

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

2017 Lasker Awards Announced: HPV Researchers and Planned Parenthood

9/8/2017

0 Comments

 
Trenton, NJ — Laurie McGinley reports in The Washington Post that The Lasker Awards, among the most prestigious in medicine, will go to two National Cancer Institute (NCI) researchers whose work led to the development of vaccines that prevent cervical cancer, and to Planned Parenthood for providing “essential health services and reproductive care” to millions of women, the Albert and Mary Lasker Foundation said today.
 
In announcing the awards, sometimes referred to as “America’s Nobels,” the foundation lauded the recipients’ efforts to protect and enhance women’s health.
 
The foundation’s praise of Planned Parenthood seemed designed to counter attacks on the nonprofit by President Donald J. Trump and top congressional Republicans, who want to end all federal funding to the organization. 
​Planned Parenthood, the nation’s biggest abortion provider, already is barred from using federal dollars for abortions.
 
The foundation also honored Michael N. Hall, a molecular biologist at the Biozentrum University of Basel, for discoveries involving the role of proteins called TOR in controlling cell growth. It said his discoveries “have broadened our understanding of the fundamental mechanisms that underlie growth, development and aging.”
 
The prizes, which come with $250,000, are awarded to researchers, clinicians and others who have made major advances in the prevention and treatment of disease.
 
They are sometimes seen as a harbinger of the Nobel Prize; 87 Lasker laureates have also won Nobels.
 
The target of the two NCI scientists honored — Douglas Lowy, the institute’s acting director, and John Schiller, a longtime researcher there — was the disease that kills 250,000 women around the world every year.
 
“They devised a blueprint for several safe and effective vaccines that promise to slash the incidence of cervical cancer and mortality,” the foundation said.
 
That work by the longtime collaborators, who will share the Lasker-DeBakey Clinical Medical Research Award, enabled the development of vaccines for the human papillomavirus. HPV also underlies cancers of the vulva, penis, anus and throat.
 
HPV infections, the most common of sexually transmitted infections, usually go away without treatment. But in the early 1980s, German virologist Harald zur Hausen linked cervical cancer to particular viral strains. “That made crystal clear that HPV was incredibly important,” Lowy said.
 
The foundation’s mission is “to improve health by accelerating support for medical research through recognition of research excellence, education, and advocacy.”
 
The foundation “celebrate(s) the contributions of scientists, clinicians, and public servants who have made major advances in the understanding, diagnosis, treatment, cure, or prevention of human disease.   Our programs educate the public and promote scientific collaboration, and we advocate for a healthier world through medical research.”
 
Mary Woodard Lasker (1901–1994) was a champion of medical research. She and her husband, pioneer advertising executive Albert Davis Lasker (1880–1952), established a legacy of advocacy and philanthropy in support of science and health.
 
Mrs. Lasker was one of the country's best known and most effective activists in the cause of increased public funding for medical research.  For decades, she tirelessly persuaded the American public that the national investment in medical research would yield invaluable benefits for human health.
 
Her simple warning was, "If you think research is expensive, try disease!" Mrs. Lasker's early efforts focused on developing public support to advance research on cancer.
 
She founded the Citizens Committee for the Conquest of Cancer and took her cause to Congress and the American public as a leading proponent of the National Cancer Act, which was signed by President Nixon in 1971.
 
Mrs. Lasker’s ardent advocacy for greater government funding of all the medical sciences contributed to increased appropriations for the National Institutes of Health as well as the creation of several NIH institutes.
 
Mrs. Lasker's work transformed the medical research enterprise, which earned her the Presidential Medal of Freedom and the Congressional Gold Medal. As a permanent monument to her efforts, in 1984 Congress named the Mary Woodard Lasker Center for Health Research and Education at the National Institutes of Health.
 
For McGinley’s full story, click here.
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.